VC fund profile · evidence-aware directory data
GV stages, portfolio and investment profile
Alphabet's venture-capital arm investing across life sciences, consumer, enterprise and frontier technology.
Keep track of GV
Save this profile to your VCT watchlist for a quick return.
Stage-based planning range
$1M–$10M
This is a planning range inferred from stage coverage, not a firm-disclosed check size.
Methodology: Stage bucket inferred from the rounds a fund leads or invests in.
No firm-specific check-size disclosure is recorded.
Investment stages
Leads: Not recorded
Participates: Seed, Series A, Series B, Series B+, Series C, Growth
Sector focus
Not recorded
Geography
Mountain View, United States
Founded Not recorded
Fund size / AUM
Not recorded
A separate fund-size evidence record is not yet available.
Portfolio in our directory
7
Linked startup profiles
Recent tracked investment
Not recorded
No dated round explicitly links this fund.
Rounds they lead
Rounds they invest
Last verified: 2026-10-01. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.
Portfolio companies we track
Startups in our directory that list GV as an investor (7 total).
- Allara Insurance-covered virtual care platform for hormonal, metabolic and reproductive health.
- Arboretum LifeSciences Molecular-information company expanding genetic testing and precision medicine into common diseases.
- Blacksmith CI cloud for GitHub Actions build and test jobs, using managed bare-metal compute, caching, observability and AI agent tooling.
- Estuary Biotherapeutics Preclinical, locally delivered gene therapies for inherited kidney disease.
- Flapping Airplanes An AI research lab developing more data-efficient models and software that gets more work from GPUs.
- Metaview AI-native recruiting intelligence and workflow platform
- OMass Therapeutics Oxford biotech developing small-molecule medicines in endocrinology and immunology.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.